Revenue: $23,732 for QQ1 2025 (YoY +124,805.3%, QoQ +1,719.94%).
Gross Profit: $23,732 (Gross Margin reported as 100% based on the data).
Operating Expenses: $1,415,427 (R&D $220,989; G&A $1,194,438).
EBITDA: -$1,362,000; EBITDARatio: -57.39%; Operating Income: -$1,391,695; Operating Income Margin: -58.64%.
Net Income: -$1,232,062; Net Income Margin: -51.92%; EPS: -$0.17.
Cash Flow: Net cash from operating activities -$1,297,485; Capex -$522,800; Free Cash Flow -$2,280,285.
Cash Position: End of period cash of $2,571,340 vs. beginning cash of $14,398,099; Net cash change -$11,826,759.
Balance Sheet (data integrity caveat): Total Assets reported as $936,462; Total Liabilities $500,748; Shareholdersโ Equity $15,649,155; Retained Earnings -$9,991,521; Cash & Cash Equivalents $2,571,340. Note: Several noncurrent asset and liability line items appear inconsistent, signaling possible misstatements in the data provided.
Liquidity/Valuation: Current Ratio 30.29; Quick Ratio 30.29; Price-to-Sales 356.97; Enterprise Value Multiple -4.33; Cash per share $2.13.
Earnings Per Share (diluted): -$0.17.